{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:23:48Z","timestamp":1792002228144,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Letrozole, an aromatase inhibitor, is used to treat breast cancer in postmenopausal women. Tumor lysis syndrome (TLS) is a complication that can trigger multiple organ failure caused by the release of intracellular nucleic acids, phosphate, and potassium into the blood due to rapid tumor cell disintegration induced by drug therapy. TLS is uncommon in solid tumors and occurs primarily in patients receiving chemotherapy. Herein, we report a rare occurrence of TLS that developed in a patient with locally advanced breast cancer following treatment with letrozole.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>An 80-year-old woman with increased bleeding from a fist-sized left-sided breast mass presented to our hospital. Histological examination led to a diagnosis of invasive ductal carcinoma of the luminal type. The patient refused chemotherapy and was administered hormonal therapy with letrozole. Seven days after letrozole initiation, she complained of anorexia and diarrhea. Blood test results revealed elevated blood urea nitrogen (BUN) and creatinine (Cr) levels, and she was admitted to our hospital for intravenous infusions. On the second day after admission, marked elevations of LDH, BUN, Cr, potassium, calcium, and uric acid levels were observed. Furthermore, metabolic acidosis and prolonged coagulation capacity were observed. We suspected TLS and discontinued letrozole, and the patient was treated with hydration, febuxostat, and maintenance hemodialysis. On the third day after admission, her respiratory status worsened because of acute respiratory distress syndrome associated with hypercytokinemia, and she was intubated. On the fourth day after admission, her general condition did not improve, and she died.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although TLS typically occurs after chemotherapy initiation, the findings from the present case confirm that this syndrome can also occur after hormonal therapy initiation and should be treated with caution.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40792-024-01901-1","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T04:01:56Z","timestamp":1713931316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tumor lysis syndrome following letrozole for locally advanced breast cancer: a case report"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7096-4188","authenticated-orcid":false,"given":"Masayuki","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Miyabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunehiro","family":"Shintani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"1901_CR1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3816\/SCT.2005.n.012","volume":"2","author":"FE Mott","year":"2005","unstructured":"Mott FE, Esana A, Chakmakjian C, Herrington JD. Tumor lysis syndrome in solid tumors. Support Cancer Ther. 2005;2:188\u201391.","journal-title":"Support Cancer Ther"},{"key":"1901_CR2","first-page":"112","volume":"16","author":"P Zigrossi","year":"2001","unstructured":"Zigrossi P, Brustia M, Bobbio F, Campanini M. Flare and tumor lysis syndrome with atypical features after letrozole therapy in advanced breast cancer. A case report. Ann Ital Med Int. 2001;16:112\u20137.","journal-title":"Ann Ital Med Int"},{"key":"1901_CR3","doi-asserted-by":"crossref","first-page":"117822342110066","DOI":"10.1177\/11782234211006677","volume":"15","author":"GE Watkinson","year":"2021","unstructured":"Watkinson GE, Hari DP. Tumour lysis syndrome in occult breast cancer treated with letrozole\u2014a rare occurrence. A case report and review. Breast Cancer (Auckl). 2021;15:11782234211006676.","journal-title":"Breast Cancer (Auckl)."},{"key":"1901_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/archsurg.1941.01210080079004","volume":"42","author":"FE Mohs","year":"1941","unstructured":"Mohs FE. Chemosurgery: a microscopically controlled method of cancer excision. Arch Surg. 1941;42:279\u201385.","journal-title":"Arch Surg"},{"key":"1901_CR5","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","volume":"26","author":"B Coiffier","year":"2008","unstructured":"Coiffier B, Altman A, Pui C, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008;26:2767\u201378.","journal-title":"J Clin Oncol"},{"key":"1901_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","volume":"127","author":"MS Cairo","year":"2004","unstructured":"Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127:3\u201311.","journal-title":"Br J Haematol"},{"key":"1901_CR7","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1182\/blood.V106.11.1843.1843","volume":"106","author":"P Montesinos","year":"2005","unstructured":"Montesinos P, Martin G, Perez-Sirbent M. Identification of risk factors for tumour lysis syndrome in patients with acute myeloid leukemia: development of a prognostic score. Blood. 2005;106:1843.","journal-title":"Blood"},{"key":"1901_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/j.ackd.2013.07.001","volume":"21","author":"FP Wilson","year":"2014","unstructured":"Wilson FP, Berns JS. Tumor lysis syndrome: new challenges and recent advances. Adv Chronic Kidney Dis. 2014;21:18\u201326.","journal-title":"Adv Chronic Kidney Dis"},{"key":"1901_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1159\/000320581","volume":"33","author":"B Coiffier","year":"2010","unstructured":"Coiffier B. Acute tumor lysis syndrome-a rare complication in the treatment of solid tumors. Onkologie. 2010;33:498\u20139.","journal-title":"Onkologie"},{"key":"1901_CR10","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.21873\/anticanres.16403","volume":"43","author":"S Omori","year":"2023","unstructured":"Omori S, Shigechi T, Kawaguchi K, Ijichi H, Oki E, Yoshizumi T. Successful prevention of tumour lysis syndrome in HER2-positive breast cancer: case report and literature review. Anticancer Res. 2023;43:2371\u20137.","journal-title":"Anticancer Res"},{"key":"1901_CR11","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1056\/NEJMra0904569","volume":"364","author":"SC Howard","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011;364:1844\u201354.","journal-title":"N Engl J Med"},{"key":"1901_CR12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1159\/000531925","volume":"16","author":"M Furusawa","year":"2023","unstructured":"Furusawa M, Matsuishi K, Horino K, Inoue H, Abe M, Oya N. A case of tumor lysis syndrome during palliative radiotherapy for breast cancer metastases. Case Rep Oncol. 2023;16:1060\u20135.","journal-title":"Case Rep Oncol"},{"key":"1901_CR13","doi-asserted-by":"crossref","first-page":"117822342110374","DOI":"10.1177\/11782234211037421","volume":"15","author":"C Handy","year":"2021","unstructured":"Handy C, Wesolowski R, Gillespie M, Lause M, Sardesai S, Williams N, et al. Tumor lysis syndrome in a patient with metastatic breast cancer treated with alpelisib. Breast Cancer (Auckl). 2021;15:11782234211037420.","journal-title":"Breast Cancer (Auckl)"},{"key":"1901_CR14","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.925248","volume":"21","author":"X Carrier","year":"2020","unstructured":"Carrier X, Gaur S, Philipovskiy A. Tumor lysis syndrome after a single dose of atezolizumab with nab-paclitaxel: a case report and review of literature. Am J Case Rep. 2020;21: e925248.","journal-title":"Am J Case Rep"},{"key":"1901_CR15","volume":"11","author":"HM Aslam","year":"2019","unstructured":"Aslam HM, Zhi C, Wallach SL. Tumor lysis syndrome: a rare complication of chemotherapy for metastatic breast cancer. Cureus. 2019;11: e4024.","journal-title":"Cureus"},{"key":"1901_CR16","volume":"11","author":"M Parsi","year":"2019","unstructured":"Parsi M, Rai M, Clay C. You can\u2019t always blame the chemo: a rare case of spontaneous tumor lysis syndrome in a patient with invasive ductal cell carcinoma of the breast. Cureus. 2019;11: e6186.","journal-title":"Cureus"},{"key":"1901_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.14740\/jmc3237","volume":"10","author":"M Idrees","year":"2019","unstructured":"Idrees M, Fatima S, Bravin E. Spontaneous tumor lysis syndrome: a rare presentation in breast cancer. J Med Case. 2019;10:24\u20136.","journal-title":"J Med Case"},{"key":"1901_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/107327481602300110","volume":"23","author":"DJ Bromberg","year":"2016","unstructured":"Bromberg DJ, Valenzuela M, Nanjappa S, Pabbathi S. Hyperuricemia in 2 patients receiving palbociclib for breast cancer. Cancer Control. 2016;23:59\u201360.","journal-title":"Cancer Control"},{"key":"1901_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13256-016-0969-5","volume":"10","author":"C Baudon","year":"2016","unstructured":"Baudon C, Duhoux FP, Sinapi I, Canon JL. Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report. J Med Case Rep. 2016;10:178.","journal-title":"J Med Case Rep"},{"issue":"308","key":"1901_CR20","first-page":"e1","volume":"33","author":"GN Vaidya","year":"2015","unstructured":"Vaidya GN, Acevedo R. Tumor lysis syndrome in metastatic breast cancer after a single dose of paclitaxel. Am J Emerg Med. 2015;33(308):e1-2.","journal-title":"Am J Emerg Med"},{"key":"1901_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s12282-013-0448-4","volume":"22","author":"F Taira","year":"2015","unstructured":"Taira F, Horimoto Y, Saito M. Tumor lysis syndrome following trastuzumab for breast cancer: a case report and review of the literature. Breast Cancer. 2015;22:664\u20138.","journal-title":"Breast Cancer"},{"key":"1901_CR22","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1345\/aph.1D164","volume":"38","author":"M Kurt","year":"2004","unstructured":"Kurt M, Eren OO, Engin H, G\u00fcler N. Tumor lysis syndrome following a single dose of capecitabine. Ann Pharmacother. 2004;38:902.","journal-title":"Ann Pharmacother"},{"key":"1901_CR23","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1023\/A:1008347226743","volume":"11","author":"AY Rostom","year":"2000","unstructured":"Rostom AY, El-Hussainy G, Kandil A, Allam A. Tumor lysis syndrome following hemi-body irradiation for metastatic breast cancer. Ann Oncol. 2000;11:1349\u201351.","journal-title":"Ann Oncol"},{"key":"1901_CR24","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1177\/106002809703101221","volume":"31","author":"Y Ust\u00fcnda\u011f","year":"1997","unstructured":"Ust\u00fcnda\u011f Y, Boyacio\u011flu S, Haznedaro\u011flu IC, Baltali E. Acute tumor lysis syndrome associated with paclitaxel. Ann Pharmacother. 1997;31:1548\u20139.","journal-title":"Ann Pharmacother"},{"key":"1901_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00000421-199502000-00015","volume":"18","author":"NT Sklarin","year":"1995","unstructured":"Sklarin NT, Markham M. Spontaneous recurrent tumor lysis syndrome in breast cancer. Am J Clin Oncol. 1995;18:71\u20133.","journal-title":"Am J Clin Oncol"},{"key":"1901_CR26","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/00000421-199412000-00010","volume":"17","author":"P Drakos","year":"1994","unstructured":"Drakos P, Bar-Ziv J, Catane R. Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature. Am J Clin Oncol. 1994;17:502\u20135.","journal-title":"Am J Clin Oncol"},{"key":"1901_CR27","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/1097-0142(19870815)60:4<762::AID-CNCR2820600409>3.0.CO;2-P","volume":"60","author":"ME Stark","year":"1987","unstructured":"Stark ME, Dyer MC, Coonley CJ. Fatal acute tumor lysis syndrome with metastatic breast carcinoma. Cancer. 1987;60:762\u20134.","journal-title":"Cancer"},{"key":"1901_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1056\/NEJM198607243150417","volume":"315","author":"P Cech","year":"1986","unstructured":"Cech P, Block JB, Cone LA, Stone R. Tumor lysis syndrome after tamoxifen flare. N Engl J Med. 1986;315:263\u20134.","journal-title":"N Engl J Med"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-024-01901-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40792-024-01901-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-024-01901-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T04:07:45Z","timestamp":1713931665000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-024-01901-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1901"],"URL":"https:\/\/doi.org\/10.1186\/s40792-024-01901-1","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"assertion":[{"value":"21 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient in the case died before consent for this case to be published could be obtained. Verbal consent was gained from family members. No identifiable data are contained within this case report. Only age, sex, and the name of the treatment center are contained within the report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}